Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 538

1.

Murine macrophage chemokine receptor CCR2 plays a crucial role in macrophage recruitment and regulated inflammation in wound healing.

Boniakowski AE, Kimball AS, Joshi A, Schaller M, Davis FM, denDekker A, Obi AT, Moore BB, Kunkel SL, Gallagher KA.

Eur J Immunol. 2018 Jun 7. doi: 10.1002/eji.201747400. [Epub ahead of print]

PMID:
29879295
2.

Heliox Adjunct Therapy for Neonates With Congenital Diaphragmatic Hernia.

Wise AC, Boutin MA, Knodel EM, Proudfoot JA, Lane BP, Evans ML, Suttner DM, Kimball AL.

Respir Care. 2018 May 22. pii: respcare.06079. doi: 10.4187/respcare.06079. [Epub ahead of print]

PMID:
29789411
3.

Adalimumab Alleviates Skin Pain in Patients with Moderate to Severe Hidradenitis Suppurativa: Secondary Efficacy Results from the PIONEER I and PIONEER II Randomized Controlled Trials.

Kimball AB, Sundaram M, Shields AL, Hudgens S, Okun M, Foley C, Ganguli A.

J Am Acad Dermatol. 2018 May 19. pii: S0190-9622(18)30809-0. doi: 10.1016/j.jaad.2018.05.015. [Epub ahead of print] No abstract available.

PMID:
29787843
4.

Assessment of Treatment-Seeking Behaviour in Patients with Psoriasis.

Golbari NM, Lockwood SJ, Porter ML, Kimball AB.

Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16778. [Epub ahead of print]

PMID:
29758088
5.

Clinical outcomes after varicose vein procedures in octogenarians within the Vascular Quality Initiative Varicose Vein Registry.

Sutzko DC, Obi AT, Kimball AS, Smith ME, Wakefield TW, Osborne NH.

J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):464-470. doi: 10.1016/j.jvsv.2018.02.008. Epub 2018 May 8.

PMID:
29752187
6.

Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Kimball AB, Augustin M, Gordon KB, Krueger GG, Pariser D, Fakharzadeh S, Goyal K, Calabro S, Lee S, Lin R, Li N, Srivastava B, Guenther L.

Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16737. [Epub ahead of print]

PMID:
29747219
7.

Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Three Randomised Controlled Trials.

Blauvelt A, Reich K, Papp KA, Kimball AB, Gooderham M, Tyring SK, Sinclair R, Thaci D, Li Q, Cichanowitz N, Green S, La Rosa C.

Br J Dermatol. 2018 May 9. doi: 10.1111/bjd.16724. [Epub ahead of print]

PMID:
29742274
8.

Current guidelines for psoriasis treatment: a work in progress.

Golbari NM, Porter ML, Kimball AB.

Cutis. 2018 Mar;101(3S):10-12.

PMID:
29718028
9.

Response to: Remission of hidradenitis suppurativa after bariatric surgery.

Golbari NM, Lee Porter M, Kimball AB.

JAAD Case Rep. 2018 Mar 9;4(3):278-279. doi: 10.1016/j.jdcr.2017.11.024. eCollection 2018 Apr. No abstract available.

10.

Efficacy and Safety of Ixekizumab Over 4 Years of Open-Label Treatment in a Phase 2 Study in Chronic Plaque Psoriasis.

Zachariae C, Gordon K, Kimball A, Lebwohl M, Blauvelt A, Leonardi C, Braun D, McKean-Matthews M, Burge R, Cameron G.

J Am Acad Dermatol. 2018 Apr 10. pii: S0190-9622(18)30505-X. doi: 10.1016/j.jaad.2018.03.047. [Epub ahead of print]

PMID:
29653208
11.

Pregnancy Outcomes after Exposure to Certolizumab Pegol: Updated Results from a Pharmacovigilance Safety Database.

Clowse MEB, Scheuerle AE, Chambers C, Afzali A, Kimball AB, Cush JJ, Cooney M, Shaughnessy L, Vanderkelen M, Förger F.

Arthritis Rheumatol. 2018 Apr 5. doi: 10.1002/art.40508. [Epub ahead of print]

PMID:
29623679
12.

Late characterisation of cardiac effects following anthracycline and trastuzumab treatment in breast cancer patients.

Kimball A, Patil S, Koczwara B, Raman KS, Perry R, Grover S, Selvanayagam J.

Int J Cardiol. 2018 Jun 15;261:159-161. doi: 10.1016/j.ijcard.2018.03.025. Epub 2018 Mar 8.

PMID:
29576422
13.

Patient-reported symptoms and signs of moderate-to-severe psoriasis treated with guselkumab or adalimumab: results from the randomized VOYAGE 1 trial.

Papp KA, Blauvelt A, Kimball AB, Han C, Randazzo B, Wasfi Y, Shen YK, Li S, Griffiths CEM.

J Eur Acad Dermatol Venereol. 2018 Mar 6. doi: 10.1111/jdv.14910. [Epub ahead of print]

PMID:
29512196
14.

Ly6CHi Blood Monocyte/Macrophage Drive Chronic Inflammation and Impair Wound Healing in Diabetes Mellitus.

Kimball A, Schaller M, Joshi A, Davis FM, denDekker A, Boniakowski A, Bermick J, Obi A, Moore B, Henke PK, Kunkel SL, Gallagher KA.

Arterioscler Thromb Vasc Biol. 2018 May;38(5):1102-1114. doi: 10.1161/ATVBAHA.118.310703. Epub 2018 Mar 1.

PMID:
29496661
15.

Increased Prevalence of Cancer in Adult Patients With Psoriasis in the United States: A Claims Based Analysis.

Kimball AB, Sundaram M, Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Guérin A, Ganguli A.

J Drugs Dermatol. 2018 Feb 1;17(2):180-186.

PMID:
29462226
16.

Host-associated bacterial community succession during amphibian development.

Prest TL, Kimball AK, Kueneman JG, McKenzie VJ.

Mol Ecol. 2018 Apr;27(8):1992-2006. doi: 10.1111/mec.14507. Epub 2018 Mar 23.

PMID:
29411448
17.

Dysfunctional Wound Healing in Diabetic Foot Ulcers: New Crossroads.

Davis FM, Kimball A, Boniakowski A, Gallagher K.

Curr Diab Rep. 2018 Jan 23;18(1):2. doi: 10.1007/s11892-018-0970-z. Review.

PMID:
29362914
18.

Carfilzomib for relapsed or refractory multiple myeloma - Authors' reply.

Dimopoulos MA, Kimball AS.

Lancet Oncol. 2018 Jan;19(1):e2. doi: 10.1016/S1470-2045(17)30920-8. No abstract available.

PMID:
29304357
19.

Understanding patient engagement in psoriasis treatment.

Golbari NM, Lockwood SJ, Porter ML, Kimball AB.

Br J Dermatol. 2018 Apr;178(4):988-989. doi: 10.1111/bjd.16266. Epub 2018 Mar 6. No abstract available.

PMID:
29274082
20.

A Beginner's Guide to Analyzing and Visualizing Mass Cytometry Data.

Kimball AK, Oko LM, Bullock BL, Nemenoff RA, van Dyk LF, Clambey ET.

J Immunol. 2018 Jan 1;200(1):3-22. doi: 10.4049/jimmunol.1701494.

PMID:
29255085
21.

Age-induced and photoinduced changes in gene expression profiles in facial skin of Caucasian females across 6 decades of age.

Kimball AB, Alora-Palli MB, Tamura M, Mullins LA, Soh C, Binder RL, Houston NA, Conley ED, Tung JY, Annunziata NE, Bascom CC, Isfort RJ, Jarrold BB, Kainkaryam R, Rocchetta HL, Swift DD, Tiesman JP, Toyama K, Xu J, Yan X, Osborne R.

J Am Acad Dermatol. 2018 Jan;78(1):29-39.e7. doi: 10.1016/j.jaad.2017.09.012. Epub 2017 Nov 14.

PMID:
29146147
22.

Adverse Reactions to Biologics in Psoriasis.

Lockwood SJ, Prens LM, Kimball AB.

Curr Probl Dermatol. 2018;53:1-14. doi: 10.1159/000478072. Epub 2017 Nov 7.

PMID:
29131033
23.

Amplified hearing device use in acute care settings for patients with hearing loss: A feasibility study.

Kimball AR, Roscigno CI, Jenerette CM, Hughart KM, Jenkins WW, Hsu W.

Geriatr Nurs. 2018 May - Jun;39(3):279-284. doi: 10.1016/j.gerinurse.2017.10.009. Epub 2017 Nov 10.

PMID:
29129447
24.

Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Strober B, Gooderham M, de Jong EMGJ, Kimball AB, Langley RG, Lakdawala N, Goyal K, Lawson F, Langholff W, Hopkins L, Fakharzadeh S, Srivastava B, Menter A.

J Am Acad Dermatol. 2018 Jan;78(1):70-80. doi: 10.1016/j.jaad.2017.08.051. Epub 2017 Nov 6.

25.

Telehealth Systems.

Mechanic OJ, Kimball AB.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 May 13.

26.

Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension.

Kimball AB, Luger T, Gottlieb A, Puig L, Kaufmann R, Burge R, Lin CY, Yosipovitch G.

Acta Derm Venereol. 2018 Jan 12;98(1):98-102. doi: 10.2340/00015555-2801.

27.

Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA).

Mehdizadeh A, Alavi A, Alhusayen R, Bauer B, Bechara FG, Bourcier M, Brassard A, Djamei V, Dutz J, George R, Ghias M, Gooderham M, Hamzavi I, Hoffman LK, Hou A, Hu H, Kimball AB, Kirchhof M, Kryzskaya D, Liy Wong MDC, Lowes MA, Lynde CW, McLellen C, Prens E, Prens L, Rogalska T, Sibbald RG, Sisic M, Tan MG, Wong DD.

Exp Dermatol. 2018 Jan;27(1):104-112. doi: 10.1111/exd.13445. Epub 2017 Nov 15.

PMID:
28898476
28.

Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial.

Dimopoulos MA, Goldschmidt H, Niesvizky R, Joshua D, Chng WJ, Oriol A, Orlowski RZ, Ludwig H, Facon T, Hajek R, Weisel K, Hungria V, Minuk L, Feng S, Zahlten-Kumeli A, Kimball AS, Moreau P.

Lancet Oncol. 2017 Oct;18(10):1327-1337. doi: 10.1016/S1470-2045(17)30578-8. Epub 2017 Aug 23.

PMID:
28843768
29.

Cover Image, Volume 173A, Number 9, September 2017.

Kruszka P, Porras AR, Addissie YA, Moresco A, Medrano S, Mok GTK, Leung GKC, Tekendo-Ngongang C, Uwineza A, Thong MK, Muthukumarasamy P, Honey E, Ekure EN, Sokunbi OJ, Kalu N, Jones KL, Kaplan JD, Abdul-Rahman OA, Vincent LM, Love A, Belhassan K, Ouldim K, El Bouchikhi I, Shukla A, Girisha KM, Patil SJ, Sirisena ND, Dissanayake VHW, Paththinige CS, Mishra R, Klein-Zighelboim E, Gallardo Jugo BE, Chávez Pastor M, Abarca-Barriga HH, Skinner SA, Prijoles EJ, Badoe E, Gill AD, Shotelersuk V, Smpokou P, Kisling MS, Ferreira CR, Mutesa L, Megarbane A, Kline AD, Kimball A, Okello E, Lwabi P, Aliku T, Tenywa E, Boonchooduang N, Tanpaiboon P, Richieri-Costa A, Wonkam A, Chung BHY, Stevenson RE, Summar M, Mandal K, Phadke SR, Obregon MG, Linguraru MG, Muenke M.

Am J Med Genet A. 2017 Sep;173(9):i. doi: 10.1002/ajmg.a.38408.

PMID:
28816424
30.

New method to induce mild traumatic brain injury in rodents produces differential outcomes in female and male Sprague Dawley rats.

Wirth P, Yu W, Kimball AL, Liao J, Berkner P, Glenn MJ.

J Neurosci Methods. 2017 Oct 1;290:133-144. doi: 10.1016/j.jneumeth.2017.07.030. Epub 2017 Aug 2.

PMID:
28780369
31.

Noonan syndrome in diverse populations.

Kruszka P, Porras AR, Addissie YA, Moresco A, Medrano S, Mok GTK, Leung GKC, Tekendo-Ngongang C, Uwineza A, Thong MK, Muthukumarasamy P, Honey E, Ekure EN, Sokunbi OJ, Kalu N, Jones KL, Kaplan JD, Abdul-Rahman OA, Vincent LM, Love A, Belhassan K, Ouldim K, El Bouchikhi I, Shukla A, Girisha KM, Patil SJ, Sirisena ND, Dissanayake VHW, Paththinige CS, Mishra R, Klein-Zighelboim E, Gallardo Jugo BE, Chávez Pastor M, Abarca-Barriga HH, Skinner SA, Prijoles EJ, Badoe E, Gill AD, Shotelersuk V, Smpokou P, Kisling MS, Ferreira CR, Mutesa L, Megarbane A, Kline AD, Kimball A, Okello E, Lwabi P, Aliku T, Tenywa E, Boonchooduang N, Tanpaiboon P, Richieri-Costa A, Wonkam A, Chung BHY, Stevenson RE, Summar M, Mandal K, Phadke SR, Obregon MG, Linguraru MG, Muenke M.

Am J Med Genet A. 2017 Sep;173(9):2323-2334. doi: 10.1002/ajmg.a.38362. Epub 2017 Jul 27.

PMID:
28748642
32.

Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis.

Feldman SR, Green L, Kimball AB, Siu K, Zhao Y, Herrera V, Nyirady J, Alexis AF.

J Dermatolog Treat. 2017 Dec;28(8):716-721. doi: 10.1080/09546634.2017.1329502. Epub 2017 Aug 3.

PMID:
28737440
33.

Psoriasis and latitude: Analytic approaches and future data needs.

Hartman RI, Kimball AB.

J Am Acad Dermatol. 2017 Aug;77(2):e59. doi: 10.1016/j.jaad.2017.04.1125. No abstract available.

PMID:
28711108
34.

The Histone Methyltransferase MLL1 Directs Macrophage-Mediated Inflammation in Wound Healing and Is Altered in a Murine Model of Obesity and Type 2 Diabetes.

Kimball AS, Joshi A, Carson WF 4th, Boniakowski AE, Schaller M, Allen R, Bermick J, Davis FM, Henke PK, Burant CF, Kunkel SL, Gallagher KA.

Diabetes. 2017 Sep;66(9):2459-2471. doi: 10.2337/db17-0194. Epub 2017 Jun 29.

35.

Macrophage-Mediated Inflammation in Normal and Diabetic Wound Healing.

Boniakowski AE, Kimball AS, Jacobs BN, Kunkel SL, Gallagher KA.

J Immunol. 2017 Jul 1;199(1):17-24. doi: 10.4049/jimmunol.1700223. Review.

PMID:
28630109
36.

Observations from our evaluation of bodyweight changes after initiation of a biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Shear NH, Alhusayen R, Fernandez-Obregon A, Kimball AB, Menter A, Wu JJ, Goyal K, Patel H, Lin R, Armstrong AW.

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):e544-e547. doi: 10.1111/jdv.14414. Epub 2017 Jul 12. No abstract available.

PMID:
28622413
37.

Notch Regulates Macrophage-Mediated Inflammation in Diabetic Wound Healing.

Kimball AS, Joshi AD, Boniakowski AE, Schaller M, Chung J, Allen R, Bermick J, Carson WF 4th, Henke PK, Maillard I, Kunkel SL, Gallagher KA.

Front Immunol. 2017 Jun 1;8:635. doi: 10.3389/fimmu.2017.00635. eCollection 2017.

38.

Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa.

Kimball AB, Sundaram M, Banderas B, Foley C, Shields AL.

J Dermatolog Treat. 2018 Mar;29(2):152-164. doi: 10.1080/09546634.2017.1341614. Epub 2017 Jul 4.

PMID:
28608738
39.

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials.

Reich K, Papp KA, Blauvelt A, Tyring SK, Sinclair R, Thaçi D, Nograles K, Mehta A, Cichanowitz N, Li Q, Liu K, La Rosa C, Green S, Kimball AB.

Lancet. 2017 Jul 15;390(10091):276-288. doi: 10.1016/S0140-6736(17)31279-5. Epub 2017 Jun 6. Erratum in: Lancet. 2017 Jul 15;390(10091):230.

PMID:
28596043
40.

A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2).

Boccia RV, Bessudo A, Agajanian R, Conkling P, Harb W, Yang H, Pinchasik D, Kimball AS, Berenson JR.

Clin Lymphoma Myeloma Leuk. 2017 Jul;17(7):433-437. doi: 10.1016/j.clml.2017.05.009. Epub 2017 May 10.

41.

Immunotherapy of Recurrent Herpes Labialis With Squaric Acid.

Palli MA, McTavish H, Kimball A, Horn TD.

JAMA Dermatol. 2017 Aug 1;153(8):828-829. doi: 10.1001/jamadermatol.2017.0725. No abstract available.

42.

Comorbidities of hidradenitis suppurativa.

Porter ML, Kimball AB.

Semin Cutan Med Surg. 2017 Jun;36(2):55-57. doi: 10.12788/j.sder.2017.018.

PMID:
28538744
43.

Itch intensity in moderate-to-severe plaque psoriasis versus atopic dermatitis: A meta-analysis.

Shahwan KT, Kimball AB.

J Am Acad Dermatol. 2017 Jun;76(6):1198-1200.e1. doi: 10.1016/j.jaad.2017.02.002. Review. No abstract available.

PMID:
28522048
44.

Pediatric Psoriasis Comorbidity Screening Guidelines.

Osier E, Wang AS, Tollefson MM, Cordoro KM, Daniels SR, Eichenfield A, Gelfand JM, Gottlieb AB, Kimball AB, Lebwohl M, Mehta NN, Paller AS, Schwimmer JB, Styne DM, Van Voorhees AS, Tom WL, Eichenfield LF.

JAMA Dermatol. 2017 Jul 1;153(7):698-704. doi: 10.1001/jamadermatol.2017.0499.

PMID:
28514463
45.

Update on biologic safety for patients with psoriasis during pregnancy.

Porter ML, Lockwood SJ, Kimball AB.

Int J Womens Dermatol. 2017 Feb 4;3(1):21-25. doi: 10.1016/j.ijwd.2016.12.003. eCollection 2017 Mar. Review.

46.

Managing the dose escalation of biologics in an era of cost containment: the need for a rational strategy.

Shahwan KT, Kimball AB.

Int J Womens Dermatol. 2016 Oct 26;2(4):151-153. doi: 10.1016/j.ijwd.2016.09.003. eCollection 2016 Dec.

47.

Hidradenitis suppurativa scoring systems: can we choose just one?

Porter ML, Kimball AB.

Cutis. 2017 Mar;99(3):156-157. No abstract available.

PMID:
28398416
48.

Getting pandemic prevention right.

Dahn B, Fallah MP, Platts J, Moon S, Kimball AM.

Lancet. 2017 Mar 25;389(10075):1189. doi: 10.1016/S0140-6736(17)30775-4. No abstract available.

PMID:
28353436
49.

Understanding the cost of dermatologic care: A survey study of dermatology providers, residents, and patients.

Steen AJ, Mann JA, Carlberg VM, Kimball AB, Musty MJ, Simpson EL.

J Am Acad Dermatol. 2017 Apr;76(4):609-617. doi: 10.1016/j.jaad.2016.11.049. Epub 2017 Feb 8.

PMID:
28189269
50.

The Impact of Administrative Burden on Academic Physicians: Results of a Hospital-Wide Physician Survey.

Rao SK, Kimball AB, Lehrhoff SR, Hidrue MK, Colton DG, Ferris TG, Torchiana DF.

Acad Med. 2017 Feb;92(2):237-243. doi: 10.1097/ACM.0000000000001461.

PMID:
28121687

Supplemental Content

Loading ...
Support Center